losartan and quercetin

losartan has been researched along with quercetin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Lombardo, F; Obach, RS; Waters, NJ1
El-Moselhy, MA; Heeba, GH; Matouk, AI; Taye, A1
Adumekwe, CW; Agomuo, EN; Amadi, PU1
Aguilar, MI; Crook, T; Del Borgo, MP; Hirmiz, B; Kiriakidi, S; Kolettas, E; Markopoulos, GS; Mavromoustakos, T; Renziehausen, A; Sayyad, N; Syed, N; Tsiailanis, AD; Tzakos, AG; Vrettos, EI; Widdop, RE1

Reviews

2 review(s) available for losartan and quercetin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
Modulatory properties of cardiac and quercetin glycosides from Dacryodes edulis seeds during L-NAME-induced vascular perturbation.
    Journal of basic and clinical physiology and pharmacology, 2020, Jul-11, Volume: 31, Issue:5

    Topics: Animals; Biomarkers; Burseraceae; Cardiac Glycosides; Dose-Response Relationship, Drug; Drug Synergism; Endothelium, Vascular; Losartan; Male; Metoprolol; Mice; NG-Nitroarginine Methyl Ester; Plant Extracts; Quercetin; Rats; Seeds

2020

Other Studies

3 other study(ies) available for losartan and quercetin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats.
    Environmental toxicology and pharmacology, 2013, Volume: 36, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Catalase; Creatine Kinase, MB Form; Cytoprotection; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Heart Diseases; L-Lactate Dehydrogenase; Lipid Peroxidation; Lipid Peroxides; Losartan; Male; Myocardium; Nitric Oxide; Quercetin; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors; Tumor Necrosis Factor-alpha

2013
Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid.
    Free radical biology & medicine, 2020, 11-20, Volume: 160

    Topics: Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Losartan; Quercetin; Temozolomide

2020